US$ 21.79
ghk cu angiogenesis vegf study Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application GHK-Cu Peptide: Clinical Evidence &
Description
Just what four decades of peer-reviewed research actually shows

doi: 10.1210/en.2005-0430 92 FaraoniEYCamillettiMAAbeledo-MaChadoARatnerLDDe FinoFHuhtaniemiIet al
In one clinical trial which consisted of 120 diabetic patients treated with 2% GHK gel, patients showed increased in the percentage of ulcer closure from 60.8% to 98.5% and decreased in the percentage of infection from 34% to 7%

When these cells get PepT1 added through transfection, KPV activity returns
